Cost-utility of Intravenous Immunoglobulin (IVIG) compared with corticosteroids for the treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in Canada

OBJECTIVES: Intravenous immunoglobulin (IVIG) has demonstrated improvement in chronic inflammatory demyelinating polyneuropathy (CIDP) patients in placebo controlled trials. However, IVIG is also much more expensive than alternative treatments such as corticosteroids. The objective of the paper is t...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Blackhouse, Gord, Gaebel, Kathryn, Xie, Feng, Campbell, Kaitryn, Assasi, Nazila, Tarride, Jean-Eric, O'Reilly, Daria, Chalk, Colin, Levine, Mitchell, Goeree, Ron
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2010
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2903512/
https://ncbi.nlm.nih.gov/pubmed/20565778
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1478-7547-8-14
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars